These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18651343)

  • 21. Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo.
    Gur E; Dremencov E; Lerer B; Newman ME
    Eur J Pharmacol; 1999 May; 372(1):17-24. PubMed ID: 10374710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300), eye blink rate and mood in young healthy subjects.
    Semlitsch HV; Anderer P; Saletu B; Binder GA; Decker KA
    Int Clin Psychopharmacol; 1993; 8(3):155-66. PubMed ID: 8263313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of venlafaxine in the sleep architecture of rats.
    Salin-Pascual RJ; Moro-Lopez ML
    Psychopharmacology (Berl); 1997 Feb; 129(3):295-6. PubMed ID: 9084070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R; Chen J; Entsuah AR; Schatzberg AF
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study.
    Safarinejad MR
    Andrologia; 2008 Feb; 40(1):49-55. PubMed ID: 18211302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in brain function during administration of venlafaxine or placebo to normal subjects.
    Leuchter AF; Cook IA; DeBrota DJ; Hunter AM; Potter WZ; McGrouther CC; Morgan ML; Abrams M; Siegman B
    Clin EEG Neurosci; 2008 Oct; 39(4):175-81. PubMed ID: 19044214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
    Silverstone PH; Entsuah R; Hackett D
    Int Clin Psychopharmacol; 2002 Nov; 17(6):273-80. PubMed ID: 12409680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.
    Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W
    Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropharmacology of venlafaxine.
    Roseboom PH; Kalin NH
    Depress Anxiety; 2000; 12 Suppl 1():20-9. PubMed ID: 11098411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.
    Kornstein SG; Pedersen RD; Holland PJ; Nemeroff CB; Rothschild AJ; Thase ME; Trivedi MH; Ninan PT; Keller MB
    J Clin Psychiatry; 2014 Jan; 75(1):62-8. PubMed ID: 24345717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
    Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
    Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.
    Homero de Souza Filho J; Bonifácio FN; Bedor DC; Ramos VL; de Sousa CE; Sardón LL; Gonçalves TM; Moreira RC; Leal LB; de Santana DP
    Clin Ther; 2010 Nov; 32(12):2088-96. PubMed ID: 21118744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine.
    Nalepa I; Manier DH; Gillespie DD; Rossby SP; Schmidt DE; Sulser F
    Eur Neuropsychopharmacol; 1998 Aug; 8(3):227-32. PubMed ID: 9716317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanol.
    Troy SM; Turner MB; Unruh M; Parker VD; Chiang ST
    J Clin Pharmacol; 1997 Nov; 37(11):1073-81. PubMed ID: 9506002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.
    Hindmarch I; Trick L; Ridout F
    Psychopharmacology (Berl); 2005 Dec; 183(2):133-43. PubMed ID: 16205916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.